JOHNSON & JOHNSON Comprehensive Income 2010-2026 | JNJ
Beta
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is JOHNSON & JOHNSON's current comprehensive income?
JOHNSON & JOHNSON (JNJ) annual comprehensive income for 2025 was $23.61B, a 59.00% increase from 2024. JOHNSON & JOHNSON comprehensive income for the quarter ending March 29, 2026 was $5.33B.
What was JOHNSON & JOHNSON's comprehensive income in 2024?
JOHNSON & JOHNSON annual comprehensive income for 2024 was $14.85B, a 50.67% decline from 2023.
What was JOHNSON & JOHNSON's comprehensive income in 2023?
JOHNSON & JOHNSON annual comprehensive income for 2023 was $30.11B, a 147.07% increase from 2022.
What is JOHNSON & JOHNSON's 4-year comprehensive income CAGR?
JOHNSON & JOHNSON comprehensive income grew at a compound annual growth rate (CAGR) of 10.28% from FY2021 to FY2025, going from $15.97B to $23.61B over 4 years.
Comprehensive Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+10.3%
FY2019
$14.45B
→
FY2025
$23.61B
1011121314161718192122232425
5 years selected
Comprehensive Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $23.61B | +59.0% | 10-K |
| FY2024 | $14.85B | -50.7% | 10-K |
| FY2023 | $30.11B | +147.1% | 10-K |
| FY2022 | $12.19B | -23.7% | 10-K |
| FY2021 | $15.97B | +10.5% | 10-K |
| FY2019 | $14.45B | +7.0% | 10-K |
| FY2018 | $13.51B | -4.7% | 10-K |
| FY2017 | $14.17B | +7.5% | 10-K |
| FY2016 | $13.18B | +55.7% | 10-K |
| FY2014 | $8.46B | -49.6% | 10-K |
| FY2013 | $16.78B | +57.2% | 10-K |
| FY2012 | $10.68B | -17.0% | 10-K |
| FY2011 | $12.86B | +11.8% | 10-K |
| FY2010 | $11.50B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →